Sabra Healthcare REIT Raised to Market Outperform From Market Perform by JMP Securities
LTC Properties, Sabra Health Care REIT Upgraded at JMP on Expected Returns
JMP Securities Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Announces Target Price $20
Jefferies Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Cuts Target Price to $20
Sabra Health Care REIT, Amazon And More: CNBC's 'Final Trades'
Express News | CNBC Final Trades: IShares US Oil & Gas Exploration & Production ETF, Amazon, Sabra Health Care REIT
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $18
Mizuho Securities Downgrades Sabra Health Care REIT Inc(SBRA.US) to Hold Rating, Raises Target Price to $20
Mizuho Downgrades Sabra Health Care REIT to Neutral From Outperform
Express News | Mizuho Downgrades Sabra Health Care REIT to Neutral, Maintains Price Target to $20
Sabra Health Care REIT Analyst Ratings
BofA Securities Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $21
Jefferies Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Raises Target Price to $21
Express News | Sabra Health Care REIT Inc : Jefferies Raises Target Price to $21 From $20
Sabra Health Care REIT Inc To Go Ex-Dividend On November 15th, 2024 With 0.3 USD Dividend Per Share
Sabra Health Care Declares $0.30 Dividend
Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript Summary
Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating
Sabra Health Care REIT Inc | 8-K: SABRA REPORTS THIRD QUARTER 2024 RESULTS; UPDATES 2024 GUIDANCE